Trifecta Research Study
NCT07717866 · Axial Therapeutic Research
What it is testing
Summary
Summary as written by the trial’s own sponsor and published on ClinicalTrials.gov API v2. It is the sponsor’s description, reproduced unedited, not an assessment by this site.
What counts as success
Primary outcome measures
PTSD Checklist for Diagnostic and Statistical Manual (DSM)-5 (PCL-5)
Measured over Up to 12 months follow up
Medical Outcomes Study Cognitive Functioning Scale (MOS-CF)
Measured over Up to 12 months follow up
Stroop Squared Task
Measured over Up to 12 months follow-up
Externalized Free Recall with Emotional Words Task
Measured over Up to 15 weeks (Post-MeRT for Group A, Post-IM/5MeO for Group B)
A trial succeeds or fails on its primary outcome, declared in advance. Everything else it reports is secondary by definition.
Who can take part
Eligibility, as published
Where
1 study site
| Facility | City | Region | Country |
|---|---|---|---|
| Axial Therapeutic Research | Northridge | California | United States |
On the registry
Contact the trial directly
This site does not enrol anyone and is not involved in this trial. To ask about taking part, use the sponsor’s own contact details on the official registry record, which is also where the most current version of everything above lives.
Before you do, the preparation checklist lists what a site will ask you on a first call and what is worth asking them. It is free and collects nothing.
NCT07717866 on ClinicalTrials.gov →
Last updated in the registry 2026-07-21. Registry records change; this page reflects the data build of 2026-08-25.
Related